Feed BMEZ
BM

BlackRock Health Sciences Term Trust

BMEZ · NYSE

$16.50 +1.48% (+$0.24)
1M -0.24%
Market Cap $1.65B
P/E Ratio 70.22x
Div. Yield 8.12%
ROE -

Bulios Fair Price

$11.12

32.6% downside

Current Price

$16.5

Undervalued Fair Value Overvalued

According to Bulios Fair Price, BMEZ is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Valuation
18 /100
Expensive
P/S 68.42x
P/B 2.14x
P/E 70.22x
Growth
38 /100
Stable
Book val. growth 7.09%
Rev. growth 26.11%
FCF growth N/A
Profitability
55 /100
Moderate
Op. margin 3.85%
Net margin 97.44%
FCF margin N/A
Quality
82 /100
Excellent
Asset turnover 0.03x
ROA 3.03%
ROE N/A
Debt
-
N/A
Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
31 /100
Unstable
Rev. volatility 179.50%
EPS volatility 85.66%
Profitable years 2

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about BMEZ
Online

Sector

Financial Services

Industry

Asset Management

CEO

John Perlowski

Employees

-

Headquarters

New York

Upcoming events

15 OCT

Ex-Dividend

Ex-dividend date

5d
30 OCT

Dividend Payment

Payment date

20d
13 NOV

Ex-Dividend

Ex-dividend date

34d
30 NOV

Dividend Payment

Payment date

51d
11 DEC

Ex-Dividend

Ex-dividend date

62d
22 DEC

Dividend Payment

Payment date

73d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.